The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
Status:
Withdrawn
Trial end date:
2010-12-31
Target enrollment:
Participant gender:
Summary
This study is a single-arm, open label protocol evaluating the use of Cleviprex to rapidly
control hypertension in patients who present with intracerebral hemorrhage (ICH) or
subarachnoid hemorrhage (SAH), and that require ICP monitoring via ventriculostomy (External
Ventricular Drain or EVD).